The latest in funding & deals: 6 developments from the past day, tracked and curated by the HealthTech Cube news desk. The lead story: Call For Applications: UNICEF Venture Funding Opportunity for Femtech Solutions 2026 | Up to US$100,000.
Rock Health Q3 2026 Market Update: Fifteen Years of Digital Health, $11.1B YTD Funding, and the Rise of AI-Native Platforms
What You Should Know Venture fund and digital health advisory firm Rock Health published its Q3 2026 Market Update in October 2026, titled Q3 2026 Market Update: Crystallizing Fifteen Years of Digital Health, commemorating the 15th annual Rock Health Summit and reflecting on the sector’s evolution since 2011. U.S.-based digital health startups raised $3.7B across ... Read More
Asahi Kasei Acquisition Pays Off With FDA Approval for Novel Herpes Drug
Asahi Kasei’s Hovilpri is now approved for treating lesions caused by herpes simplex virus infection. This daily pill came from the $919 million acquisition of AiCuris Anti-Infective Cures. The post Asahi Kasei Acquisition Pays Off With FDA Approval for Novel Herpes Drug appeared first on MedCity News.
Follow the full firehose on the HTC Wire, refreshed automatically every day.